2025-03-24 12:23:59
Latest Post
NIIT Limited offers gNIIT, a customizable dual qualification program for undergraduate students
TVS Holdings Limited declares interim dividend of Rs. 93- Roni Households Limited allots 57,46,546 bonus shares
Pasupati Acrylon Limited commissions 150 KL Ethanol Plant
SBC Exports Ltd receives repeat Export Order, ties up with Day-to-Day retail chain
Stock Report
Rossari Biotech Ltd Q2 FY2025 consolidated profit up at Rs. 35.33 crores
Posted On : 2024-10-20 13:56:51( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended September 30, 2024.
Financial Results (Q2 FY2025) - QoQ Comparison
The company has reported total income of Rs. 499.070 crores during the period ended September 30, 2024 as compared to Rs. 490.598 crores during the period ended June 30, 2024.
The company has posted net profit / (loss) of Rs. 35.333 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs. 34.899 crores for the period ended June 30, 2024.
The company has reported EPS of Rs. 6.38 for the period ended September 30, 2024 as compared to Rs. 6.30 for the period ended June 30, 2024.
| Financials | Q2 FY2025 | Q1 FY2025 | % Change |
| Total Income | ₹ 499.070 crs | ₹490.598 crs |  1.73% |
| Net Profit | ₹35.333 crs | ₹34.899 crs | 1.24% |
| EPS | ₹6.38 | ₹6.30 | 1.27% |
Financial Results (Q2 FY2025) - YoY Comparison
The company has reported total income of Rs. 499.070 crores during the period ended September 30, 2024 as compared to Rs.484.832 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.35.333 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs.32.948 crores for the period ended September 30, 2023.
The company has reported EPS of Rs.6.38 for the period ended September 30, 2024 as compared to Rs.5.95 for the period ended September 30, 2023.
| Financials | Q2 FY2025 | Q2 FY2024 | % Change |
| Total Income | ₹ 499.070 crs | ₹484.832 crs | 2.94% |
| Net Profit | ₹35.333 crs | ₹32.948 crs | 7.24% |
| EPS | ₹6.38 | ₹5.95 | 7.23% |
Financial Results (Half Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.989.668 crores during the 6 Months period ended September 30, 2024 as compared to Rs.897.628 crores during the 6 Months period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.70.232 crores for the 6 Months period ended September 30, 2024 as against net profit / (loss) of Rs.62.167 crores for the 6 Months period ended September 30, 2023.
The company has reported EPS of Rs.12.69 for the 6 Months period ended September 30, 2024 as compared to Rs.11.24 for the 6 Months period ended September 30, 2023.
| Financials | Half Year Ended FY2025 | Half Year Ended FY2024 | % Change |
| Total Income | ₹989.668 crs | ₹897.628 crs | 10.25% |
| Net Profit | ₹70.232 crs | ₹62.167 crs | 12.97% |
| EPS | ₹12.69 | ₹11.24 | 12.90% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 875.10 as compared to the previous close of Rs. 877.65. The total number of shares traded during the day was 4843 in over 444 trades.
The stock hit an intraday high of Rs. 895.00 and intraday low of 856.25. The net turnover during the day was Rs. 4253536.00.
